Preoperative sentinel lymph node identification, biopsy and localisation using contrast enhanced ultrasound (CEUS) in patients with breast cancer: a systematic review and meta-analysis

World Cancer Research Fund International (WCRF), 2012 Fisher, 2002, Twenty year follow up of a randomised trial comparing total mastectomy, lumpectomy and lumpectomy plus irradiation for the treatment of breast cancer, N Engl J Med, 347, 1233, 10.1056/NEJMoa022152 Veronesi, 2002, Twenty year follow up of a randomised study comparing breast-conserving surgery with radical mastectomy for early breast cancer, N Engl J Med, 347, 1227, 10.1056/NEJMoa020989 Fisher, 1983, Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update, Cancer, 52, 1551, 10.1002/1097-0142(19831101)52:9<1551::AID-CNCR2820520902>3.0.CO;2-3 Jatoi, 1999, Significance of axillary lymph node metastasis in primary breast cancer, J Clin Oncol, 17, 2334, 10.1200/JCO.1999.17.8.2334 Benson, 2007, Management of the axilla in patients with breast cancer, Lancet Oncol, 8, 331, 10.1016/S1470-2045(07)70103-1 Lyman, 2014, Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update, J Clin Oncol, 32, 1365, 10.1200/JCO.2013.54.1177 Mansel, 2006, Randomised multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial, J Natl Cancer Inst, 98, 599, 10.1093/jnci/djj158 Krag, 2007, Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial, Lancet Oncol, 8, 881, 10.1016/S1470-2045(07)70278-4 Kuehn, 2000, Long-term morbidity following axillary dissection in breast cancer patients—clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factors, Breast Cancer Res Treat, 64, 275, 10.1023/A:1026564723698 Hack, 1999, Physical and psychological morbidity after axillary lymph node dissection for breast cancer, J Clin Oncol, 17, 143, 10.1200/JCO.1999.17.1.143 Veronesi, 2003, A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer, N Engl J Med, 349, 546, 10.1056/NEJMoa012782 Gill, 2009, Sentinel-lymph-node-based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): a randomized controlled surgical trial, Ann Surg Oncol, 16, 266, 10.1245/s10434-008-0229-z Giuliano, 1994, Lymphatic mapping and sentinel lymphadenectomy for breast cancer, Ann Surg, 3, 391, 10.1097/00000658-199409000-00015 Krag, 1993, Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe, Surg Oncol, 2, 335, 10.1016/0960-7404(93)90064-6 Veronesi, 2006, Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study, Lancet Oncol, 7, 983, 10.1016/S1470-2045(06)70947-0 Krag, 2010, Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial, Lancet Oncol, 11, 927, 10.1016/S1470-2045(10)70207-2 Collins, 2005, The sentinel node in breast cancer: an update, Cancer Imaging, 5, S3, 10.1102/1470-7330.2005.0039 Kim, 2006, Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis, Cancer, 106, 4, 10.1002/cncr.21568 Buscombe, 2007, Sentinel node in breast cancer procedural guidelines, Eur J Nucl Med Mol Imaging, 34, 2154, 10.1007/s00259-007-0614-z Newman, 2007, Lymphatic mapping techniques and sentinel lymph node biopsy in breast cancer, Surg Clin North Am, 87, 353, 10.1016/j.suc.2007.01.013 Fowler, 2009, A pilot study of dual-isotope lymphoscintigraphy for breast sentinel node biopsy comparing intradermal and intraparenchymal injection, Eur J Surg Oncol, 35, 1041, 10.1016/j.ejso.2009.02.018 Keshtgar, 2011, Implementing sentinel lymph node biopsy programs in developing countries: challenges and opportunities, World J Surg, 35, 1159, 10.1007/s00268-011-0956-3 Goyal, 2006, Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer—results of the ALMANAC validation phase, Breast Cancer Res Treat, 99, 203, 10.1007/s10549-006-9192-1 Dixon, 2009, Effectiveness of immediate preoperative injection of radiopharmaceutical and blue dye for sentinel node biopsy in patients with breast cancer, Eur J Cancer, 45, 795, 10.1016/j.ejca.2008.11.011 Barthelmes, 2010, Adverse reactions to patent blue V dye—the NEW START and ALMANAC experience, Eur J Surg Oncol, 36, 399, 10.1016/j.ejso.2009.10.007 Bézu, 2011, Anaphylactic response to blue dye during sentinel lymph node biopsy, Surg Oncol, 20, e55, 10.1016/j.suronc.2010.10.002 White, 2011, Sentinel lymph node biopsy in early breast cancer surgery—working with the risks of vital blue dye to reap the benefits, Eur J Surg Oncol, 37, 101, 10.1016/j.ejso.2010.12.007 Gumus, 2013, How long will I be blue? Prolonged skin staining following sentinel lymph node biopsy using intradermal patent blue dye, Breast Care, 8, 199, 10.1159/000352092 Rescigno, 2009, Patterns of axillary surgical care for breast cancer in the era of sentinel lymph node biopsy, Ann Surg Oncol, 16, 687, 10.1245/s10434-008-0195-5 Acuna, 2014, Assessing patterns of practice of sentinel lymph node biopsy for breast cancer in Latin America, World J Surg, 38, 1077, 10.1007/s00268-013-2382-1 Deo, 2009, Sentinel lymph node biopsy for breast cancer—Indian perspective, Indian J Surg, 71, 326, 10.1007/s12262-009-0088-2 Buccimazza, 2011, Implementing sentinel lymph node biopsy programs in developing countries: challenges and opportunities, World J Surg, 35, 1155, 10.1007/s00268-011-1040-8 Kelley, 2010, Tracer agents for the detection of sentinel lymph nodes in breast cancer: current concerns and directions for the future, J Surg Oncol, 104, 91, 10.1002/jso.21791 National Institute for Health and Care Excellence, 2009 Association of Breast Surgery (ABS) Consensus Statement. Management of the malignant axilla in early breast cancer. Association of Breast Surgery Trustees 16th March 2015. Available at: http://www.associationofbreastsurgery.org.uk/axilla_abs_consensus_statement_16_3_15. (Accessed 8 January 2016). Diepstraten, 2014, Value of preoperative ultrasound-guided axillary lymph node biopsy for preventing completion axillary lymph node dissection in breast cancer: a systematic review and meta-analysis, Ann Surg Oncol, 21, 51, 10.1245/s10434-013-3229-6 Goldberg, 2004, Radiology sentinel lymph nodes in a swine model with melanoma: lymphatic US, Radiology, 230, 727, 10.1148/radiol.2303021440 Omoto, 2006, Sentinel node detection in breast cancer using contrast-enhanced sonography with 25% albumin—initial clinical experience, J Clin Ultrasound, 34, 317, 10.1002/jcu.20241 Sever, 2009, Preoperative localization of sentinel lymph nodes using intradermal microbubbles and contrast-enhanced ultrasonography in patients with breast cancer, Br J Surg, 96, 1295, 10.1002/bjs.6725 Omoto, 2009, Sentinel node detection method using contrast-enhanced ultrasonography with Sonazoid in breast cancer: preliminary clinical study, Ultrasound Med Biol, 35, 1249, 10.1016/j.ultrasmedbio.2009.02.004 Houssami, 2014, Clinical utility of ultrasound-needle biopsy for preoperative staging of the axilla in invasive breast cancer, Anticancer Res, 34, 1087 Sever, 2012, Sentinel node identification using microbubbles and contrast-enhanced ultrasonography, Clin Radiol, 67, 687, 10.1016/j.crad.2011.11.009 Tacconelli, 2009, Systematic reviews: CRD's guidance for undertaking reviews in health care, Lancet Infect Dis, 10, 226, 10.1016/S1473-3099(10)70065-7 Khan, 2011 Liberati, 2009, The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration, BMJ, 339, b2700, 10.1136/bmj.b2700 Sharma, 2015, Evaluation of the use of microbubbles in the ultrasound assessment of the axilla in breast cancer patients Cochrane Community, 2014 Bossuyt, 2013, Chapter 11: Interpreting results and drawing conclusions Higgins, 2011 Zamora, 2006, Meta-DiSc: a software for meta-analysis of test accuracy data, BMC Med Res Methodol, 10.1186/1471-2288-6-31 Lee, 2015, Systematic review and meta-analysis of studies evaluating diagnostic test accuracy: a practical review for clinical researchers—part II. Statistical methods of meta-analysis, Korean J Radiol, 16, 1188, 10.3348/kjr.2015.16.6.1188 Whiting, 2011, Research and reporting methods accuracy studies, Ann Intern Med, 155, 529, 10.7326/0003-4819-155-8-201110180-00009 Reitsma, 2009, 9 Assessing methodological quality Sever, 2012, Preoperative needle biopsy of sentinel lymph nodes using intradermal microbubbles and contrast-enhanced ultrasound in patients with breast cancer, AJR Am J Roentgenol, 199, 465, 10.2214/AJR.11.7702 Cox, 2016, Contrast-enhanced ultrasound biopsy of sentinel lymph nodes in patients with breast cancer: implications for axillary metastases and conservation, Ann Surg Oncol, 23, 58, 10.1245/s10434-015-4606-0 Rautiainen, 2015, Contrast-enhanced ultrasound-guided axillary lymph node core biopsy: diagnostic accuracy in preoperative staging of invasive breast cancer, Eur J Radiol, 84, 2130, 10.1016/j.ejrad.2015.08.006 Macaskill, 2010, Chapter 10: Analysing and Presenting Results Sever, 2011, Preoperative sentinel node identification with ultrasound using microbubbles in patients with breast cancer, AJR Am J Roentgenol, 196, 251, 10.2214/AJR.10.4865 Omoto K, Futsuhara K, Sekine O, et al. Sentinel node identification method using contrast-enhanced ultrasonography with Sonazoid injected subareolarly in breast cancer. A multicenter study. In Off Proc 13th World Congr World Fed Ultrasound Med Biol Vienna, Austria, 26-29 August. 2011;37(8):S108. Cheng L, Zhang D, Xie F, et al. Sentinel lymph node biopsy under the guidance of preoperative contrast-enhanced ultrasound imaging using mircobubbles in patients with breast cancer. In: 9th European Breast Cancer Conference (EBCC), Glasgow, Scotland, 19-21 March, 2014. Eur J Cancer. 2014;50(Suppl. 2):S144. Xie, 2015, Intradermal microbubbles and contrast-enhanced ultrasound (CEUS) is a feasible approach for sentinel lymph node identification in early-stage breast cancer, World J Surg Oncol, 13, 319, 10.1186/s12957-015-0736-x Barentsz, 2015, Sentinel lymph node localization with contrast-enhanced ultrasound and an 125I seed: an ideal prospective development study, Int J Surg, 14, 1, 10.1016/j.ijsu.2014.12.019 Esfehani, 2015, Validation of contrast enhanced ultrasound technique to wire localization of sentinel lymph node in patients with early breast cancer, Indian J Surg Oncol, 10 Britton, 2009, Use of ultrasound-guided axillary node core biopsy in staging of early breast cancer, Eur Radiol, 19, 561, 10.1007/s00330-008-1177-5 Houssami, 2011, Preoperative ultrasound-guided needle biopsy of axillary nodes in invasive breast cancer, Ann Surg, 254, 243, 10.1097/SLA.0b013e31821f1564 Britton, 2009, Ultrasound guided percutaneous axillary lymph node core biopsy: how often is the sentinel lymph node being biopsied?, Breast, 18, 13, 10.1016/j.breast.2008.09.003 Galimberti, 2013, Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial, Lancet Oncol, 14, 297, 10.1016/S1470-2045(13)70035-4 Giuliano, 2010, Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases, Ann Surg, 252, 423, 10.1097/SLA.0b013e3181f08f32 Giuliano, 2011, Axillary dissection vs no axillary dissection in women with invasive breast cancer, JAMA, 305, 569, 10.1001/jama.2011.90 Gatzemeier, 2013, Which sentinel lymph-node (SLN) positive breast cancer patient needs an axillary lymph-node dissection (ALND)—ACOSOG Z0011 results and beyond, Breast, 22, 211, 10.1016/j.breast.2013.02.001 Boland, 2015, Axillary nodal burden in primary breast cancer patients with positive pre-operative ultrasound guided fine needle aspiration cytology: management in the era of ACOSOG Z011, Eur J Surg Oncol, 41, 559, 10.1016/j.ejso.2015.01.011 Dodwell, 2015, Axillary conservation in early breast cancer, Br J Surg, 102, 1297, 10.1002/bjs.9881 Maguire, 2016, Sentinel lymph nodes for breast carcinoma: an update on current practice, Histopathology, 68, 152, 10.1111/his.12853 Mittendorf, 2014, Incorporating the results of the American College of Surgeons Oncology Group Z0011 trial into clinical practice, Curr Breast Cancer Rep, 6, 17, 10.1007/s12609-013-0131-y Hieken, 2014, The promise of axillary imaging in individualized surgical management of breast cancer patients: another step forward, Ann Surg Oncol, 14 Caudle, 2014, Predicting the extent of nodal disease in early-stage breast cancer, Ann Surg Oncol, 21, 3440, 10.1245/s10434-014-3813-4 Farrell, 2015, The Z0011 trial: is this the end of axillary ultrasound in the pre-operative assessment of breast cancer patients?, Eur Radiol, 2682, 10.1007/s00330-015-3683-6 Verheuvel, 2015, The role of ultrasound-guided lymph node biopsy in axillary staging of invasive breast cancer in the post-ACOSOG Z0011 trial era, Ann Surg Oncol, 22, 409, 10.1245/s10434-014-4071-1 Veronesi, 1997, Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes, Lancet, 349, 1864, 10.1016/S0140-6736(97)01004-0 Caudle, 2015, Less remains better: morbidity after axillary surgery, Ann Surg Oncol Ann Surg Oncol, 22, 4, 10.1245/s10434-014-3936-7 Diepstraten, 2014, Ultrasound-guided minimally invasive complete excision of the sentinel node in breast cancer patients, Eur J Cancer, 50, S151 Yang, 2011, Microbubble contrast-enhanced ultrasound for sentinel lymph node detection: ready for prime time?, AJR Am J Roentgenol, 196, 249, 10.2214/AJR.10.5707 Ahmed, 2014, Novel techniques for sentinel lymph node biopsy in breast cancer: a systematic review, Lancet Oncol, 15, e351, 10.1016/S1470-2045(13)70590-4 Gkegkes, 2015, Contrast enhanced ultrasound (CEU) using microbubbles for sentinel lymph node biopsy in breast cancer: a systematic review, Acta Chir Belg, 115, 212, 10.1080/00015458.2015.11681099 Hu, 2013, [Clinical application of sentinel lymph node biopsy under the guidance of contrast-enhanced ultrasound plus methylene blue in patients with breast cancer], Zhonghua Yi Xue Za Zhi, 93, 1255 Deville, 2002, Conducting systematic review of diagnostic studies: didactic guidelines, BMC Med Res Methodol, 2, 9, 10.1186/1471-2288-2-9 Cox, 2015, The identification and biopsy of sentinel lymph nodes using intradermal microbubbles and CEUS in Preoperative Breast Cancer Patients